What it's for (Indications)
- Dexibuprofen, the pharmacologically active S(+)-enantiomer of ibuprofen, is indicated for the symptomatic treatment of mild to moderate pain and inflammation.
- This includes various conditions such as acute musculoskeletal pain, including sprains and strains, as well as symptomatic relief of osteoarthritis and rheumatoid arthritis.
- It is also effectively used for the management of primary dysmenorrhea, dental pain, and post-operative pain.
- Furthermore, dexibuprofen is utilized for its antipyretic properties in febrile conditions when appropriate.
- Its targeted action offers therapeutic benefits in reducing pain intensity and inflammatory responses across a spectrum of acute and chronic painful and inflammatory states, improving patient comfort and functional capacity through its anti-inflammatory, analgesic, and antipyretic effects.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The recommended adult dosage of dexibuprofen typically ranges from 200 mg to 400 mg, administered orally, two to three times daily. The maximum recommended daily dose usually does not exceed 1200 mg. It is generally advisable to take dexibuprofen with food or milk to minimize gastrointestinal upset. The precise dosage and frequency should be tailored to the individual patient's condition, severity of pain or inflammation, and response to treatment, always using the lowest effective dose for the shortest possible duration to control symptoms. Dosage adjustments may be necessary in patients with renal or hepatic impairment, and caution is warranted in these populations. Adherence to prescribed dosages is crucial to optimize efficacy and mitigate potential risks associated with NSAID therapy, and doses should not be increased beyond recommended limits without professional medical guidance. |
Safety & Warnings
Common Side Effects
- Dexibuprofen, like other non-steroidal anti-inflammatory drugs (NSAIDs), can be associated with a range of side effects, varying in severity.
- Common adverse reactions primarily involve the gastrointestinal system, including dyspepsia, nausea, vomiting, abdominal pain, diarrhea, and constipation.
- Central nervous system effects such as headache and dizziness are also frequently reported.
- More serious, though less common, side effects include gastrointestinal ulceration, bleeding, and perforation, which can be life-threatening.
- Cardiovascular risks encompass hypertension, edema, and an increased risk of thrombotic events such as myocardial infarction and stroke.
- Renal impairment, ranging from acute kidney injury to interstitial nephritis, and hepatic dysfunction, characterized by elevated liver enzymes, can also occur.
- Hypersensitivity reactions, including skin rashes, pruritus, angioedema, and bronchospasm, are possible.
- Patients should be advised to seek immediate medical attention if they experience any severe or persistent side effects, or signs of allergic reactions, or gastrointestinal bleeding.
Serious Warnings
- Black Box Warning: As with all systemic non-steroidal anti-inflammatory drugs (NSAIDs), dexibuprofen carries two prominent Black Box Warnings issued by regulatory authorities, highlighting significant potential risks. These warnings necessitate careful patient selection, counseling, and monitoring throughout the course of treatment with dexibuprofen. Healthcare providers should weigh the potential benefits against these significant risks, especially in patients with pre-existing conditions or those requiring long-term therapy. **CARDIOVASCULAR THROMBOTIC EVENTS:** NSAIDs, including dexibuprofen, increase the risk of serious cardiovascular thrombotic events, including myocardial infarction (MI) and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use. Patients with known cardiovascular disease or risk factors for cardiovascular disease may be at greater risk. Dexibuprofen is contraindicated in the setting of coronary artery bypass graft (CABG) surgery. **GASTROINTESTINAL RISK:** NSAIDs, including dexibuprofen, increase the risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at greater risk for serious GI events.
- Careful consideration and caution are warranted when prescribing or using dexibuprofen, particularly in specific patient populations.
- Patients with a history of gastrointestinal diseases, such as ulcerative colitis or Crohn's disease, should be closely monitored due to the increased risk of exacerbation.
- Elderly patients are at a higher risk of experiencing serious adverse effects, including gastrointestinal bleeding and renal impairment, necessitating lower doses and closer monitoring.
- Pre-existing cardiovascular conditions, such as hypertension or heart failure, require judicious use and monitoring for fluid retention and edema, as NSAIDs can exacerbate these conditions.
- Patients with asthma, especially those with aspirin sensitivity, may experience NSAID-induced bronchospasm.
- Renal and hepatic function should be assessed before and during prolonged treatment.
- Concomitant use with other NSAIDs, anticoagulants, or antiplatelet agents increases the risk of bleeding.
- Dexibuprofen may mask the signs of infection, delaying appropriate treatment.
- It should be used with caution during pregnancy (especially not in the third trimester) and lactation, and its use may impair female fertility.
- Discontinue use if significant adverse effects occur.
How it Works (Mechanism of Action)
Dexibuprofen exerts its therapeutic effects primarily through the inhibition of cyclooxygenase (COX) enzymes, specifically the COX-2 isoform, which is predominantly induced at sites of inflammation. By blocking COX-2, dexibuprofen effectively reduces the synthesis of prostaglandins, prostacyclins, and thromboxanes, which are key lipid mediators involved in the inflammatory response, pain sensitization, and fever. While it exhibits some selectivity for COX-2, it retains a degree of COX-1 inhibition, contributing to its broad analgesic, anti-inflammatory, and antipyretic properties. The reduction in prostaglandin synthesis at inflammatory sites is directly responsible for alleviating pain, decreasing swelling, and lowering elevated body temperature. This mechanism underlies its efficacy in managing various inflammatory and painful conditions, differentiating it from traditional opioids or paracetamol by directly addressing the inflammatory cascade through its modulation of arachidonic acid metabolism.